Search Results - "Rahjerdi, Ahmad Karimi"

Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years by Gholami, Fatemeh, Hamidi Farahani, Ramin, Karimi Rahjerdi, Ahmad, Ahi, Mohammadreza, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Ansarifar, Akram, Basiri, Pouria, Moradi, Milad, Jahangiri, Arash, Naderi, Kosar, Ghasemi, Soheil, Khatami, Pezhman, Honari, Mohsen, Khodaverdloo, Samane, Shooshtari, Mohammad, Mehr Azin, Hajar, Moradi, Sohrab, Shafaghi, Batool, Allahyari, Hossein, Monazah, Arina, Khodaei Poor, Ali, Taghva, Zahra, Bakhshande, Hooman, Karimi Nia, Mohammad, Solaymani Dodaran, Masoud, Forooghizade, Mohsen

“…The FAKHRAVAC®, an inactivated SARS-CoV-2 vaccine, was assessed for safety and immunogenicity in a phase II trial. We did a phase II, single-centered,…”
Get full text

Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial by Solaymani-Dodaran, Masoud, Basiri, Pouria, Moradi, Milad, Gohari, Kimiya, Sheidaei, Ali, Ahi, Mohammadreza, Ghafoori Naeeni, Farzad, Ansarifar, Akram, Rahimi, Zahra, Gholami, Fatemeh, Karimi Rahjerdi, Ahmad, Hamidi Farahani, Ramin, Naderi Saffar, Kosar, Ghasemi, Soheil, Shooshtari, Ali, Honari, Mohsen, Mozafari, Ali, Khodaverdloo, Samane, Forooghizadeh, Mohsen

“…We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. We conducted a multicenter, parallel-group, active-control, non-inferiority clinical trial…”
Get full text

Development of Inactivated FAKHRAVAC® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models by Ghasemi, Soheil, Naderi Saffar, Kosar, Ebrahimi, Firooz, Khatami, Pezhman, Monazah, Arina, Alizadeh, Ghorban-Ali, Ettehadi, Hossein-Ali, Rad, Iman, Nojehdehi, Shahrzad, Kehtari, Mousa, Kouhkan, Fatemeh, Barjasteh, Hesam, Moradi, Sohrab, Ghorbani, Mohammad-Hosein, Khodaeipour, Ali, Papizadeh, Moslem, Najafi, Roghayeh, Naghneh, Ehsan, Sadeghi, Davood, Karimi Rahjerdi, Ahmad

“…The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health…”
Get full text

Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial by Ahi, Mohammadreza, Hamidi Farahani, Ramin, Basiri, Pouria, Karimi Rahjerdi, Ahmad, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Gholami, Fatemeh, Moradi, Milad, Ghafoori Naeeni, Farzad, Saffar, Kosar Naderi, Ghasemi, Soheil, Barati, Babak, Moradi, Sohrab, Monazah, Arina, Pouranvari, Fatemeh, Forooghizadeh, Mohsen

“…Purpose: This study was completed to assess the immunogenicity and safety of the FAKHRAVAC and BBIBP-CorV vaccines as a booster dose in the population with a…”
Get full text

Immunogenic Evaluation of Bivalent Vaccine Candidate against Enterohemorrhagic and Enterotoxigenic Escherichia coli by Karimi Rahjerdi, Ahmad, Jafari, Mahyat, Motamedi, Mohammad Javad, Amani, Jafar, Salmanian, Ali Hatef

“…Caused by bacterial, viral, and parasitic pathogens, diarrhea is the second leading cause of death among children under five. Two strains of E. coli, namely…”
Get full text

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial by Ansarifar, Akram, Farahani, Ramin Hamidi, Rahjerdi, Ahmad Karimi, Ahi, Mohammadreza, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Gholami, Fatemeh, Basiri, Pouria, Moradi, Milad, Jahangiri, Arash, Naderi, Kosar, Ghasemi, Soheil, Khatami, Pezhman, Honari, Mohsen, Khodaverdloo, Samane, Shooshtari, Mohammad, Azin, Hajar Mehr, Moradi, Sohrab, Shafaghi, Batool, Allahyari, Hossein, Monazah, Arina, Poor, Ali Khodaei, Bakhshande, Hooman, Taghva, Zahra, Nia, Mohammad Karimi, Dodaran, Masoud Solaymani, Foroughizadeh, Mohsen

“…The FAKHRAVAC®, an inactivated SARS-CoV-2 vaccine, was assessed for safety and immunogenicity. In this double-blind, placebo-controlled, phase I trial, we…”
Get full text

Oral immunization with a plant-derived chimeric protein in mice: Toward the development of a multipotent edible vaccine against E. coli O157: H7 and ETEC by Shojaei Jeshvaghani, Fatemeh, Amani, Jafar, Kazemi, Rouhollah, Karimi Rahjerdi, Ahmad, Jafari, Mahyat, Abbasi, Shahsanam, Salmanian, Ali Hatef

“…•Diarrhea represents a major health problem in developing countries.•Early immunization against ETEC and EHEC may be an effective preventive strategy.•Oral…”
Get full text